TRAIL Coated Genetically Engineered Immunotherapeutic Nano-Ghosts Vesicles Target Human Melanoma-Avoiding the Need for High Effective Therapeutic Concentration of TRAIL (2021)

First Author: Levy L
Attributed to:  MSCTRAIL for lung cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/adfm.202105701

Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85117152113

Type: Journal Article/Review

Parent Publication: Advanced Functional Materials

Issue: 1